Prospective Study
Copyright ©The Author(s) 2024.
World J Clin Oncol. Mar 24, 2024; 15(3): 419-433
Published online Mar 24, 2024. doi: 10.5306/wjco.v15.i3.419
Table 1 Characteristics of patients in the cohort, n (%)
Characteristic
LN metastasis (+)
LN metastasis (-)
P value
Age, mean ± SD70.18 ± 6.7571.92 ± 7.490.39
Tumor size, mean ± SD3.89 ± 1.553.18 ± 1.640.24
Sex 0.54
        Male10 (66.67)13 (76.47)
        Female5 (33.33)4 (23.53)
CEA 0.99
        0-5 ng/mL15 (99.99)16 (94.12)
        > 5 ng/mL0 (0.01)1 (5.88)
Squamous cell carcinoma antigen0.61
        0-2.7 ng/mL12 (80.0)14 (82.35)
        > 2.7 ng/mL3 (20.00)3 (17.65)
Location0.99
        Upper mediastinal2 (13.33)1 (5.88)
        Middle mediastinal6 (40.00)8 (47.06)
        Lower mediastinal6 (40.00)8 (47.06)
        Abdominal1 (6.67)0 (0.01)
Histologic grade0.40
        Well differentiated0 (0.01)2 (11.77)
        Moderately differentiated11 (73.33)11 (64.71)
        Poorly differentiated4 (26.67)4 (23.53)
T stage 0.01
        13 (20.00)10 (58.82)
        212 (80.00)5 (29.41)
        30 (0.01)2 (11.77)
CT-reported LN status0.16
        0-10.0 mm6 (40.00)11 (64.71)
        > 10.0 mm9 (60.00)6 (35.29)